Biotech Innovator InstaMed® Pharmaceuticals Appoints Tracy Gibbs, PhD, as Chief Executive Officer Ahead of Worldwide Launch of Non-Injectable Peptide Platform
Tremonton
Archived
•
July 27, 2026
•
Backed by successful double-blinded pharmacokinetic study data and nine pending patents, the biotechnology pioneer prepares for the August 3 launch of five next-generation oral dissolving peptide films.
Source: https://www.tremontonleader.com/search/?f=rss&t=article&l=50&c=news* - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



